An article featuring Paxman was published in the very prestigious Forbes Magazine on May 29th, covering the impact of chemotherapy-induced alopecia, scalp cooling and patient motivations, as well as Paxman’s role and history, inspired by Sue Paxman.
It talks about how scalp cooling is more than “just hair”, and the profound sense of control, identity and dignity it gives cancer patients who are already suffering during an incredibly challenging time.
The article also touches on key points within the scalp cooling landscape including the merger with Dignitana, and particularly for the United States, where affordability, new reimbursement legislation, and CPT codes are an important topic and a strong focus for Paxman.
Forbes also highlights the ongoing product development for prevention of chemotherapy-induced peripheral neuropathy and commitment to improving efficacy of existing scalp cooling technology.
Finally, coming full circle, it reminds us of the goals still left to achieve, inspired by Sue Paxman and the legacy she left behind.
